Travere therapeutics and vifor pharma announce licensing agreement for the commercialization of sparsentan in europe, australia and new zealand

Vifor pharma obtains exclusive commercialization rights for sparsentan in europe, australia and new zealand

TVTX Ratings Summary

TVTX Quant Ranking